科研製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/01/20 | 4,259 | 4,282 | 4,226 | 4,233 | -29 | -0.7% | 119,800 |
| 2025/01/17 | 4,252 | 4,280 | 4,236 | 4,262 | +10 | +0.2% | 90,900 |
| 2025/01/16 | 4,281 | 4,297 | 4,246 | 4,252 | -29 | -0.7% | 113,000 |
| 2025/01/15 | 4,269 | 4,297 | 4,244 | 4,281 | +24 | +0.6% | 115,000 |
| 2025/01/14 | 4,282 | 4,310 | 4,253 | 4,257 | -17 | -0.4% | 146,300 |
| 2025/01/10 | 4,312 | 4,338 | 4,256 | 4,274 | -44 | -1% | 102,100 |
| 2025/01/09 | 4,438 | 4,440 | 4,290 | 4,318 | -121 | -2.7% | 111,100 |
| 2025/01/08 | 4,515 | 4,515 | 4,439 | 4,439 | -98 | -2.2% | 130,700 |
| 2025/01/07 | 4,579 | 4,599 | 4,525 | 4,537 | -40 | -0.9% | 176,900 |
| 2025/01/06 | 4,515 | 4,603 | 4,483 | 4,577 | +64 | +1.4% | 294,000 |
| 2024/12/30 | 4,500 | 4,530 | 4,464 | 4,513 | +13 | +0.3% | 202,700 |
| 2024/12/27 | 4,563 | 4,591 | 4,434 | 4,500 | +326 | +7.8% | 528,800 |
| 2024/12/26 | 4,163 | 4,174 | 4,143 | 4,174 | +2 | ±0% | 78,900 |
| 2024/12/25 | 4,221 | 4,224 | 4,141 | 4,172 | -50 | -1.2% | 63,600 |
| 2024/12/24 | 4,258 | 4,258 | 4,213 | 4,222 | -35 | -0.8% | 90,800 |
| 2024/12/23 | 4,237 | 4,271 | 4,221 | 4,257 | +20 | +0.5% | 99,600 |
| 2024/12/20 | 4,216 | 4,251 | 4,203 | 4,237 | +31 | +0.7% | 192,200 |
| 2024/12/19 | 4,251 | 4,280 | 4,182 | 4,206 | -97 | -2.3% | 132,900 |
| 2024/12/18 | 4,310 | 4,326 | 4,282 | 4,303 | +3 | +0.1% | 106,800 |
| 2024/12/17 | 4,305 | 4,385 | 4,293 | 4,300 | +9 | +0.2% | 188,900 |
| 2024/12/16 | 4,300 | 4,311 | 4,249 | 4,291 | -21 | -0.5% | 103,700 |
| 2024/12/13 | 4,319 | 4,347 | 4,293 | 4,312 | -34 | -0.8% | 162,900 |
| 2024/12/12 | 4,315 | 4,381 | 4,315 | 4,346 | +37 | +0.9% | 207,900 |
| 2024/12/11 | 4,336 | 4,360 | 4,302 | 4,309 | -27 | -0.6% | 113,700 |
| 2024/12/10 | 4,390 | 4,403 | 4,266 | 4,336 | -46 | -1% | 190,800 |
| 2024/12/09 | 4,357 | 4,405 | 4,336 | 4,382 | +33 | +0.8% | 228,700 |
| 2024/12/06 | 4,339 | 4,369 | 4,321 | 4,349 | +28 | +0.6% | 203,500 |
| 2024/12/05 | 4,265 | 4,321 | 4,256 | 4,321 | +66 | +1.6% | 223,700 |
| 2024/12/04 | 4,312 | 4,312 | 4,248 | 4,255 | -57 | -1.3% | 141,100 |
| 2024/12/03 | 4,325 | 4,345 | 4,298 | 4,312 | -5 | -0.1% | 218,700 |
| 2024/12/02 | 4,314 | 4,331 | 4,282 | 4,317 | -6 | -0.1% | 140,300 |
| 2024/11/29 | 4,295 | 4,333 | 4,241 | 4,323 | +10 | +0.2% | 147,500 |
| 2024/11/28 | 4,299 | 4,338 | 4,287 | 4,313 | +23 | +0.5% | 142,800 |
| 2024/11/27 | 4,307 | 4,353 | 4,259 | 4,290 | -40 | -0.9% | 263,800 |
| 2024/11/26 | 4,414 | 4,416 | 4,308 | 4,330 | -52 | -1.2% | 280,000 |
| 2024/11/25 | 4,478 | 4,490 | 4,381 | 4,382 | -79 | -1.8% | 221,400 |
| 2024/11/22 | 4,453 | 4,498 | 4,417 | 4,461 | +23 | +0.5% | 209,000 |
| 2024/11/21 | 4,448 | 4,542 | 4,416 | 4,438 | +3 | +0.1% | 245,100 |
| 2024/11/20 | 4,486 | 4,497 | 4,421 | 4,435 | -67 | -1.5% | 205,800 |
| 2024/11/19 | 4,530 | 4,544 | 4,442 | 4,502 | -59 | -1.3% | 253,000 |
| 2024/11/18 | 4,395 | 4,577 | 4,373 | 4,561 | +181 | +4.1% | 392,300 |
| 2024/11/15 | 4,386 | 4,398 | 4,316 | 4,380 | +4 | +0.1% | 257,000 |
| 2024/11/14 | 4,369 | 4,420 | 4,310 | 4,376 | +13 | +0.3% | 289,000 |
| 2024/11/13 | 4,330 | 4,448 | 4,302 | 4,363 | +53 | +1.2% | 451,000 |
| 2024/11/12 | 4,093 | 4,318 | 4,093 | 4,310 | +268 | +6.6% | 636,800 |
| 2024/11/11 | 3,939 | 4,075 | 3,935 | 4,042 | +173 | +4.5% | 378,900 |
| 2024/11/08 | 3,906 | 3,909 | 3,751 | 3,869 | -20 | -0.5% | 164,500 |
| 2024/11/07 | 3,885 | 3,919 | 3,883 | 3,889 | +27 | +0.7% | 89,000 |
| 2024/11/06 | 3,890 | 3,905 | 3,861 | 3,862 | -31 | -0.8% | 101,900 |
| 2024/11/05 | 3,885 | 3,901 | 3,873 | 3,893 | +8 | +0.2% | 73,800 |
101～
150
件表示中 / 3722件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 科研薬 | 386,700円 | -6.4% | -71.8% | 4.91% | 43.07倍 | 0.96倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| ジーエヌアイ | 379,000円 | +21.7% | +999.9% | 0.00% | 15.88倍 | 5.25倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 鳥居薬 | 634,000円 | +7.1% | -35.0% | 0.00% | 52.42倍 | 1.46倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| 東和薬品 | 297,800円 | +7.9% | -3.3% | 2.69% | 8.28倍 | 0.86倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| ゼリア新薬 | 203,500円 | +3.1% | -6.5% | 2.36% | 9.44倍 | 1.00倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム
